Cyclerion Therapeutics Files 8-K on Shareholder Votes & Financials
Ticker: CYCN · Form: 8-K · Filed: Jun 18, 2025 · CIK: 1755237
| Field | Detail |
|---|---|
| Company | Cyclerion Therapeutics, Inc. (CYCN) |
| Form Type | 8-K |
| Filed Date | Jun 18, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, corporate-governance, financials
TL;DR
Cyclerion filed an 8-K on June 18th covering shareholder votes and financials from June 16th.
AI Summary
Cyclerion Therapeutics, Inc. filed an 8-K on June 18, 2025, reporting on matters submitted to a vote of security holders and financial statements. The filing date for this report is June 18, 2025, with the earliest event reported on June 16, 2025. The company is incorporated in Massachusetts and its principal executive offices are located in Cambridge, MA.
Why It Matters
This 8-K filing provides updates on important corporate actions, including votes by security holders and financial statements, which are crucial for investors to understand the company's governance and financial health.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of corporate events and financial information, not indicating any immediate operational or financial distress.
Key Numbers
- 001-38787 — SEC File Number (Identifies the company's filing history with the SEC.)
- 83-1895370 — IRS Employer Identification Number (Unique tax identification number for the company.)
Key Players & Entities
- Cyclerion Therapeutics, Inc. (company) — Registrant
- June 18, 2025 (date) — Date of Report
- June 16, 2025 (date) — Earliest event reported
- Massachusetts (location) — State of incorporation
- Cambridge, MA (location) — Principal executive offices
FAQ
What specific matters were submitted to a vote of security holders?
The filing indicates 'Submission of Matters to a Vote of Security Holders' as an item, but the specific details of these matters are not provided in the excerpt.
What financial statements are included in this filing?
The filing lists 'Financial Statements and Exhibits' as an item, but the specific financial statements are not detailed in the provided text.
What is the exact date of the earliest event reported?
The earliest event reported is dated June 16, 2025.
Where are Cyclerion Therapeutics, Inc.'s principal executive offices located?
The principal executive offices are located at 245 First Street, 18th Floor, Cambridge, Massachusetts 02142.
What is the company's standard industrial classification?
The company's standard industrial classification is 'PHARMACEUTICAL PREPARATIONS [2834]'.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 18, 2025 regarding Cyclerion Therapeutics, Inc. (CYCN).